Colossal Biosciences logo

Colossal Biosciences Inc.

Biotechnology

Colossal Biosciences Stock

Colossal Laboratories & Bioscience is a pioneering bioscience company dedicated to de-extinction. By integrating advanced genetic science and innovative technology, Colossal aims to resurrect extinct species. The company’s mission focuses on enhancing biodiversity, restoring ecological balance, and advancing genetic research to create a sustainable future through ecological and genetic restoration efforts.

For more Colossal Biosciences stock information, or to buy or sell private shares, sign up for a MicroVentures account.

Colossal Biosciences Company Overview

Colossal is at the forefront of the bioscience industry, aiming to revive extinct species through groundbreaking genetic technology. The company employs advanced gene editing techniques, including CRISPR, to bring back species such as the woolly mammoth, the thylacine, and the dodo. This ambitious endeavor seeks not only to resurrect these creatures but also to restore lost ecosystems, promoting biodiversity and ecological balance. Colossal's work goes beyond de-extinction, encompassing significant research in biosciences and conservation. Their projects aim to address critical environmental issues, such as climate change and habitat loss, by reintroducing species that can revitalize and stabilize ecosystems. For instance, the woolly mammoth is believed to help combat climate change by transforming tundra into grassland, thus reducing greenhouse gas emissions. The company boasts a team of top-tier scientists and industry experts, all dedicated to pioneering advancements in genetic research and ecological restoration. These efforts include creating genetic toolkits for other species, which can be used to prevent extinctions and improve genetic diversity among endangered populations. Colossal is also committed to ethical considerations in its projects, ensuring that de-extinction efforts do not harm current ecosystems or existing species. By collaborating with conservationists, environmentalists, and regulatory bodies, Colossal aims to set standards and best practices for the emerging field of de-extinction science. In addition to their core projects, Colossal engages in public education and outreach to raise awareness about the importance of biodiversity and the potential of genetic technologies. Through partnerships with academic institutions, conservation organizations, and governments, the company works to advance policies and initiatives that support ecological restoration and biodiversity enhancement. Colossal's innovative approach positions it as a leader in the intersection of genetics, conservation, and technology, with the ultimate goal of creating a more sustainable and biodiverse future.

Funding Information

News

Dallas-based Colossal hatches chicks from fully artificial eggs

A Texas-based biosciences company says it has hatched live chicks from fully artificial eggs. Colossal hopes the technology will help recreate the genome of the South Island giant moa, a wingless bird that roamed New Zealand until the 1400s.

Colossal’s Dire Wolves Are Fully Grown And Hunting Together

The dire wolves are moving together as a pack and beginning to hunt. Here’s what we learned during our visit and what's coming next.

Colossal Biosciences gets $60M from UAE, building modern-day Noah’s Ark in Dubai

Colossal Biosciences announced late Monday it had received a $60 million investment from the United Arab Emirates, and the first location of its planned BioVault conservation initiative.

Biotech company Colossal, which brought dire wolves back to life, acquires Viagen

This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris Hilton and Barbra Streisand.

TIME | The Best Inventions of 2025

Here are the 300 best inventions making the world better, smarter, and more fun.

Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion

Colossal Biosciences, the world’s de-extinction company, today announces several milestones in avian cellular science, bringing the dodo revival one step closer. The Colossal Avian Genetics Group has successfully grown pigeon primordial germ cells (PGCs) for the first time in history, a pivotal step in bringing back the dodo. In addition to this breakthrough, Colossal has also announced an additional expansion of $120M in new funding.